Listen to this article. Choose between:

It often begins with the person lying beside him. She wakes to the snoring, then to the silence that follows, and waits for the breath that seems to take too long to return. When it does, it may arrive as a choke, a snort, or a sudden shift of the body before the pattern begins again. She nudges him onto his side, moves to another room, or lies awake listening, while he remains largely unaware of what has happened. By morning, both are tired for different reasons. Her sleep has been repeatedly interrupted by the sound and uncertainty of his breathing. His has been interrupted from within, by airway collapse, falling oxygen, and brief arousals he will not remember. What appears to him as a full night in bed may have been, for both of them, a night without sustained rest.

The morning after that kind of night can feel uncomfortably easy to misread. The body is heavy before the day has properly begun. Concentration takes longer to gather. An afternoon dip feels less like ordinary tiredness and more like a loss of reserve. Exercise that once felt restorative now feels harder to recover from, and blood pressure may remain stubborn despite the usual attention to medication, food, and activity. These changes are easy to place under the broad heading of getting older because they arrive gradually, overlap with familiar midlife complaints, and rarely point toward one obvious cause.

Obstructive sleep apnea complicates that interpretation because the problem is not simply how long a person sleeps. It is whether sleep remains stable enough for recovery to take place. During an obstructive event, the airway narrows or closes while the effort to breathe continues. Oxygen can fall, carbon dioxide can rise, and the brain briefly interrupts sleep so the airway can reopen. Breathing resumes, but the body has already shifted into a defensive state. Heart rate and blood pressure increase, the body’s alert response rises, and sleep architecture, the normal progression through lighter sleep, deep sleep, and REM, is disturbed. When this sequence repeats through the night, sometimes dozens of times an hour, unconsciousness can be mistaken for rest.

Seen in that light, sleep apnea is not just a defect in nighttime breathing. The airway is the entry point to a wider physiological disruption, and CPAP acts at the beginning of that sequence.

The obvious feature of obstructive sleep apnea is the interruption in breathing, but the interruption itself is only the beginning of the event. During sleep, the muscles that help keep the tongue, soft palate, and throat positioned forward relax. In someone with a vulnerable upper airway, that relaxation allows the passage to narrow or close even though the chest and diaphragm continue trying to draw air in. The body is still making the effort to breathe. The route has simply become unstable. For a few seconds, airflow falls or stops, oxygen begins to decline, carbon dioxide rises, and the pressure inside the chest changes as the respiratory muscles pull against a blocked airway. What looks from the outside like a pause in breathing is, from the inside, a short period of escalating physiological strain.

As oxygen falls and breathing effort rises, the disturbance becomes large enough to trigger a brief arousal. The sleeper may shift position, tighten the muscles around the airway, gasp, snort, or take several deeper breaths. Once the airway opens, oxygen recovers and breathing settles, but the system has not returned to an undisturbed baseline. Heart rate has changed, blood pressure has risen, and the sympathetic nervous system, the body’s automatic alert response, has been activated. A few minutes later, as the airway muscles relax again, the same sequence may begin once more.

This repetition is what changes the meaning of the disorder. One obstruction would be an isolated disturbance. Dozens of events an hour create a night organized around recovery from the last event and vulnerability to the next. The pattern resembles a smoke alarm that is repeatedly triggered and reset, not because the alarm is malfunctioning, but because the condition that sets it off keeps returning. Each response is protective in the moment. The problem is the frequency.

Sleep apnea usually produces intermittent hypoxia, repeated drops and recoveries in blood oxygen, rather than one continuous period of low oxygen. That repeated pattern can increase oxidative stress and inflammatory signalling. It can also impair the inner lining of the blood vessels, making the vascular system more reactive. At the same time, each arousal triggers another burst of the body’s alert response. Blood pressure may surge as the airway opens, then partially settle before the next event. Over time, this can help explain why untreated sleep apnea is associated with harder-to-control hypertension and why the effects of the night may continue into the day.

Sleep architecture is also altered, often in ways the sleeper cannot feel directly. Restorative sleep depends not only on duration but on continuity, with the brain moving through lighter sleep, deeper slow-wave sleep, and REM in a repeating pattern. Respiratory arousals break that sequence into smaller fragments. A man may spend eight hours in bed and still obtain less consolidated deep and REM sleep than the clock would suggest. The next-day result can look surprisingly ordinary: slower concentration, irritability, reduced exercise tolerance, morning headaches, nocturia, lower libido, or the sense that recovery now requires more effort than it used to.

CPAP intervenes at the narrowest point in the entire sequence. It delivers a steady stream of pressurized room air through a mask, creating enough internal support to keep the upper airway from collapsing as the throat muscles relax. Clinicians sometimes describe this as a pneumatic splint. The pressure holds the passage open so his own breathing can continue.

That mechanical action can make CPAP seem almost too basic for the number of systems affected by untreated apnea. It does not directly lower inflammation, restore insulin sensitivity, improve concentration, or reduce blood pressure. It acts earlier than all of those outcomes. By preventing the collapse, it removes the event that would otherwise set off the oxygen drop, the brief awakening, the surge in the body’s alert response, and the increase in cardiovascular workload.

CPAP is also different from supplemental oxygen. Oxygen can raise the level in the blood, but it does not keep the airway from closing. CPAP does. The intervention is mechanically simple, but preventing the obstruction changes everything that would otherwise follow it.

The difference may be felt quickly in some people. A man who began treatment with marked daytime sleepiness may notice that he no longer fights to stay alert in the afternoon, or that he wakes without the familiar pressure of a morning headache. His partner may notice the change first because the room becomes quieter and the long pauses in breathing disappear, which can mean her own sleep is less broken too. Other changes are less immediate and less dramatic. Concentration may become steadier over several weeks. Nocturia may lessen. Blood pressure may improve modestly, particularly when it had been difficult to control.

The effectiveness of CPAP is often discussed as though treatment begins when the machine is prescribed. Biologically, it begins only when the mask is on, the pressure is adequate, and the airway is being held open. A machine beside the bed has no residual effect once it is removed. If a man sleeps for seven hours but wears CPAP for three, the airway is protected for those three hours and vulnerable for the remaining four.

The familiar four-hour threshold can add to the confusion. It is widely used in insurance policies, clinical reporting, and research as a marker of adherence, but it is not the point at which treatment becomes complete. Four hours may provide meaningful exposure, especially compared with no use, but it still leaves part of the night untreated. The practical target is not to cross an administrative line. It is to stabilize the airway for the full period of sleep, including naps when they occur. REM sleep, the stage associated with vivid dreaming and greater muscle relaxation, becomes more concentrated toward the latter part of the night.

That is why treatment assignment and actual treatment exposure are not the same thing. A study can assign a person to CPAP without telling us how much of the night the airway was actually protected. For the body, the relevant question is simpler than the research language suggests: how many hours was the airway open enough to let sleep remain continuous? Effective nightly use is not an extra requirement added to CPAP. It is the treatment.

A man who removes the mask during the night is often described as non-compliant, as though the problem were a failure of commitment. Sometimes he may simply need time to adjust, but poor use is frequently more informative than that label suggests. A mask that leaks toward the eyes, pressure that creates a sense of air hunger, a dry mouth that wakes him repeatedly, nasal congestion that makes breathing uncomfortable, or air collecting in the stomach can turn treatment into another source of disrupted sleep. In those situations, the issue is not whether he understands that CPAP matters. The treatment setup is not yet working with the conditions of his sleep.

This is why fit matters so much. The machine can generate the correct pressure and still deliver a poor experience if the interface between the person and the treatment is wrong. Facial structure, beard growth, sleeping position, mouth breathing, nasal resistance, sensitivity to pressure, and the tendency to move during sleep all influence how well a mask works. Pressure settings matter too. Some people struggle when the machine begins too forcefully, while others feel unable to draw a satisfying breath if the starting pressure is too low. Modern devices can reveal whether large leaks, pressure changes, or residual events are occurring, but those numbers require interpretation.

Insomnia can make the picture more complicated. Someone who already spends long periods awake may become acutely aware of the mask, the airflow, and every point of contact against the face. CPAP may then be blamed for wakefulness that existed before treatment, even though the device has made the experience more noticeable. Nasal obstruction creates a similar mismatch. Congestion from allergies, structural narrowing, or chronic irritation can make pressurized airflow uncomfortable and increase the likelihood of mouth breathing, dryness, and leak. Heated humidification may help, but sometimes medical assessment is needed before the treatment can become tolerable.

The useful approach is therefore investigative rather than moral. Device data can show when the mask was removed, how much leak occurred, whether pressure climbed sharply, and whether residual events remained. The person’s experience adds the part the machine cannot measure: whether he felt trapped, congested, bloated, unable to exhale comfortably, or too awake to tolerate the sensation. Together, those details form a map of where the treatment system is breaking down. The goal is not to endure a badly configured machine through force of will. It is to adjust the system until protecting the airway is no longer a competing source of disruption.

CPAP is most reliable when the outcome being measured is close to the obstruction itself. While the mask is on and the pressure is effective, respiratory events usually fall sharply, oxygen becomes more stable, and the repeated arousals caused by airway collapse are reduced. This is the treatment’s clearest physiological effect. A night broken apart by respiratory disruptions becomes quieter internally as well as externally.

The effects that a person notices during the day are less uniform because they depend on what was present before treatment. Someone who regularly struggled to remain awake while reading, driving, or sitting through an afternoon meeting may experience a marked improvement in alertness. Another man may never have described himself as sleepy, despite severe apnea on testing, and may notice only a modest change in how he feels. That difference does not necessarily mean the treatment has worked for one person and failed for the other. It may mean that the symptom being judged was not prominent at the start.

The same restraint is needed when thinking about blood pressure. Untreated sleep apnea can contribute to repeated nighttime surges and may make hypertension more difficult to control, particularly when oxygen disruption is severe. CPAP removes one recurring driver, but average reductions in blood pressure are usually modest rather than transformative. CPAP does not guarantee cardiovascular protection. Its broader benefit appears to depend on actual nightly use, oxygen burden, symptoms, existing disease, and treatment duration.

This becomes more complicated when the question shifts from blood pressure to heart attack, stroke, or cardiovascular death. Large clinical trials have not consistently shown that prescribing CPAP to broad groups automatically prevents these outcomes. Any broader benefit appears to depend on the particular pattern of apnea, symptoms, oxygen loss, and existing health risk rather than on a universal effect. Cognitive improvement follows a similar pattern. Sleep apnea is associated with difficulties in attention, memory, and executive function, yet CPAP does not restore every cognitive domain in every person. The treatment appears better suited to preventing repeated ongoing disruption than to reversing every consequence that may have accumulated over years.

Persistent symptoms after effective treatment therefore deserve investigation rather than a simple verdict. They may indicate inadequate mask time, residual events, continued oxygen instability, or a poorly fitted setup. They may also reveal that sleep apnea was one layer of a larger problem. Once the nightly obstruction is controlled, other causes of fatigue can become easier to see.

Sleep apnea rarely behaves in isolation. Body weight, nasal airflow, alcohol, sleeping position, sedating medications, insomnia, hypertension, diabetes, and atrial fibrillation can all shape how severe the disorder is and how visible its consequences become. CPAP addresses airway collapse. Other interventions address other parts of the system. If CPAP cannot be sustained despite careful troubleshooting and support, mandibular advancement devices, positional therapy, selected surgery, or hypoglossal nerve stimulation may be worth considering. None of those options is interchangeable with CPAP, but each is a way of matching treatment to the part of the system that is still driving instability.

The first question is exposure. Is CPAP being used for the full sleep period, including naps? A man may wear CPAP for four or five hours and receive a technically acceptable adherence report, yet still remove it before the final hours of the night or leave it off during naps. If those untreated periods contain substantial apnea, the machine can appear effective while total exposure remains incomplete. Usage data should therefore be compared with actual sleep duration rather than interpreted in isolation.

Next, look at leak. A small amount of airflow escaping around the mask may not affect treatment, but larger or persistent leaks can reduce effective pressure, disturb sleep, dry the mouth, and make machine-generated event estimates less reliable. Then consider residual events. A low machine-reported apnea score usually suggests that the airway is being controlled well, but the device is estimating events from airflow rather than reproducing a full sleep study. A persistently elevated residual score may reflect inadequate pressure, major leak, positional obstruction, central events, or the need for further clinical assessment. It does not measure every aspect of sleep architecture, brain activity, or oxygenation in the same way as laboratory polysomnography.

Where clinically relevant, oxygen stability and sleep continuity matter too. Daytime sleepiness may improve first, particularly in someone who was markedly sleepy before treatment. Morning headaches may become less frequent. Nocturia may ease. Concentration may feel more reliable, and the need to recover from routine activity may lessen. A partner may notice that breathing is steady and the room remains quiet. Blood pressure may shift modestly over time, especially when it had been difficult to control. These changes are useful not because each one proves success on its own, but because together they suggest that nighttime stability is carrying into the day.

Finally, compare the data with lived experience. Effective CPAP does not guarantee perfect energy, uninterrupted sleep, lower weight, normal blood pressure, or protection from every cardiovascular event. A man may still wake because of pain, prostate-related nocturia, alcohol, stress, or insomnia. He may continue to feel tired because his sleep opportunity remains too short. If breathing is controlled but symptoms remain, the right response is not to declare the machine useless. It is to ask what the remaining pattern is now revealing.

The deeper value of treating obstructive sleep apnea is not that every symptom disappears or every risk returns to baseline. It is that one recurring source of instability is removed from the night. Breathing becomes more continuous, oxygen fluctuates less, the body’s alert response is recruited less often, and sleep has a better chance to progress without being repeatedly interrupted. The change is mechanical at first, but its significance is broader because it alters the conditions under which the brain, cardiovascular system, metabolism, and stress response are trying to recover.

For a man in the second half of life, that distinction can be clarifying. Fatigue, poor concentration, irritability, reduced exercise tolerance, nocturia, and harder-to-control blood pressure are often interpreted through the language of age. Sometimes age is part of the picture. But age does not explain every pattern, and it should not become a catch-all for physiological strain that is occurring night after night. Untreated apnea can make normal changes in reserve feel steeper by reducing the amount of stable recovery available to buffer them.

CPAP does not return the body to an earlier decade, nor should that be the standard by which it is judged. Its role is more precise. It prevents a vulnerable airway from repeatedly destabilizing the rest of the system. The machine does not create recovery. It restores the conditions in which recovery can proceed with fewer interruptions.

It emerges from how multiple systems interact and adapt over time, often in ways that aren’t obvious when viewed in isolation.

If you want a clearer way to think about that, I’ve outlined the systems perspective in a short guide you can download here:

The Midlife Health Reset — 10 core systems that shape strength, energy, and long-term health after 50.

Sources

Benjafield, A. V., et al. (2025). Positive airway pressure therapy and all-cause and cardiovascular mortality in people with obstructive sleep apnoea: a systematic review and meta-analysis of randomised controlled trials and confounder-adjusted, non-randomised controlled studies. Lancet Respiratory Medicine, 13(5), 403-413. https://pubmed.ncbi.nlm.nih.gov/40118084/

Bratton, D. J., Gaisl, T., Schlatzer, C., & Kohler, M. (2015). Comparison of the effects of continuous positive airway pressure and mandibular advancement devices on sleepiness in patients with obstructive sleep apnoea: a network meta-analysis. Lancet Respiratory Medicine, 3(11), 869-878. https://pubmed.ncbi.nlm.nih.gov/26497082/

Labarca, G., Saavedra, D., Dreyse, J., Jorquera, J., & Barbe, F. (2020). Efficacy of CPAP for improvements in sleepiness, cognition, mood, and quality of life in elderly patients with OSA: systematic review and meta-analysis of randomized controlled trials. Chest, 158(2), 751-764. https://pubmed.ncbi.nlm.nih.gov/32289311/

Li, J., Yan, W., Yi, M., Lin, R., Huang, Z., & Zhang, Y. (2023). Efficacy of CPAP duration and adherence for cognitive improvement in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials. Sleep and Breathing, 27(3), 973-982. https://pubmed.ncbi.nlm.nih.gov/35930191/

Patil, S. P., Ayappa, I. A., Caples, S. M., Kimoff, R. J., Patel, S. R., & Harrod, C. G. (2019). Treatment of adult obstructive sleep apnea with positive airway pressure: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 15(2), 335-343. https://pubmed.ncbi.nlm.nih.gov/30736887/

Patil, S. P., Ayappa, I. A., Caples, S. M., Kimoff, R. J., Patel, S. R., & Harrod, C. G. (2019). Treatment of adult obstructive sleep apnea with positive airway pressure: An American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. Journal of Clinical Sleep Medicine, 15(2), 301-334. https://pubmed.ncbi.nlm.nih.gov/30736888/

Pengo, M. F., et al. (2025). Effect of CPAP therapy on blood pressure in patients with obstructive sleep apnoea: a worldwide individual patient data meta-analysis. European Respiratory Journal, 65(1), 2400837. https://pubmed.ncbi.nlm.nih.gov/39401854/

Sánchez-de-la-Torre, M., et al. (2023). Adherence to CPAP treatment and the risk of recurrent cardiovascular events: A meta-analysis. JAMA, 330(13), 1255-1265. https://pubmed.ncbi.nlm.nih.gov/37787793/